Kaleido Biosciences, Inc. (KLDO)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Jan 23, 2026, 3:46 PM EST
Kaleido Biosciences Market Cap
Kaleido Biosciences has a market cap or net worth of $4.26 thousand as of January 23, 2026.
Market Cap
4.26K
Enterprise Value
n/a
Revenue
1.10M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since February 28, 2019, Kaleido Biosciences's market cap has decreased from 413.61M to 4.26K, a decrease of -100.00%. That is a compound annual growth rate of -81.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 4.26K | - |
| Dec 30, 2025 | 4.26K | 9,811.63% |
| Dec 31, 2024 | 43.00 | - |
| Dec 29, 2023 | 43.00 | -99.80% |
| Dec 30, 2022 | 21.31K | -99.98% |
| Dec 31, 2021 | 101.80M | -68.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 28, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| FluoroPharma Medical | 5.52K |
| Better Therapeutics | 5.45K |
| Syros Pharmaceuticals | 5.37K |
| MultiCell Technologies | 5.00K |
| Panbela Therapeutics | 4.86K |
| ONE Bio | 4.19K |
| Xeno Transplants | 4.04K |
| Synovics Pharmaceuticals | 3.65K |